Synthetic lethality targeting LKB1 mutant and EGFR wild type human non-small cell lung cancer cells by glucose starvation and SGLT2 inhibition
Y. Ren, J. Chen, X. Mo, Q. Yang, P. Chen, G. Lu, H. W.-S. Tan, J. Yi, Q. Yu, Y.-S. Kim, K. Mallilankaraman, H.-M. Shen
This study identifies glucose starvation and SGLT2 inhibition as synthetic lethal strategies for EGFR-WT/LKB1-mutant NSCLC, showing efficacy in xenograft models.
bioRxiv · Apr 29, 2019 · PreprintCancer Biology